Naohiko Fujii
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Naohiko Fujii has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Takayuki Hamano
Department of Nephrology, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan
8 shared publications - Yoshitaka Isaka
Department of Nephrology, The University of Osaka Graduate School of Medicine, Osaka, Japan
5 shared publications - Isao Matsui
Department of Nephrology, Graduate School of Medicine, The University of Osaka, Suita, Japan
4 shared publications - Kunihiro Yamagata
Division of Preventive and Sports Nephrology, Graduate School of Comprehensive Human Sciences, University of Tsukuba , Ibaraki
4 shared publications - Atsushi Wada
Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan
3 shared publications - Ichiei Narita
Niigata University
3 shared publications
Latest Publications
- 10 July 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (10) , 1753-1761
Intradialytic Renal Rehabilitation and Mortality
Key Points: Intradialytic renal rehabilitation was associated with higher 3-year survival in patients on maintenance hemodialysis. This association was directionally consistent after multivariable adjustment and propensity score matching. The association seemed stronger in men with severe frailty; no rehabilitation-related adverse events were reported. Background: Frailty and sarcopenia are increasingly common among patients undergoing maintenance hemodialysis. Globally, some countries, including Japan, have recently introduced insurance reimbursement for intradialytic renal rehabilitation, a supervised intradialytic exercise instruction plus nutritional and lifestyle guidance. However, the survival benefit has not been fully evaluated. Methods: We evaluated 708 adult outpatients on dialysis (age, 69.8±11.2 years; men, 59%; and Clinical Frailty Scale ≥6, 13%) at ten institutions across Japan in January 2021 who were retrospectively assessed over a 3-year period, including 228 patients who received intradialytic renal rehabilitation, defined as supervised intradialytic exercise instruction plus nutritional and lifestyle guidance (≥1 session/wk for≥1 month), and 480 who did not receive this intervention. Cox regression models and propensity score matching were used to compare 3-year mortality after adjustment for the Clinical Frailty Scale, comorbidities, laboratory data, and other baseline characteristics. Results: During the follow-up, deaths were observed in 14.9% of the rehabilitation group and 23.1% of the nonrehabilitation group ( P = 0.01). Three-year survival was higher with rehabilitation (84.6% versus 75.6%, P = 0.007), particularly among men and those with severe frailty. In Cox models, renal rehabilitation was consistently associated with lower mortality (crude hazard ratio [HR], 0.59 [95% confidence interval (CI), 0.40 to 0.87]; adjusted HR 0.66 [0.44 to 1.00]). After propensity score matching, the association remained directionally similar (HR, 0.65 [0.40 to 1.05]). Sex-stratified analyses suggested a stronger association among men (adjusted HR, 0.49 [0.27 to 0.89]) than among women (adjusted HR, 0.98 [0.54 to 1.77]), although the formal test for interaction was not statistically significant ( P for interaction = 0.13). Patients meeting exercise-habit criteria (≥2 sessions/wk, ≥30 minutes for ≥1 year) also showed better survival relative to the nonexercise-habit group (adjusted HR 0.60 [0.37 to 0.96], P = 0.03). No adverse events related to rehabilitation were reported. Conclusions: Intradialytic renal rehabilitation may be associated with better survival in patients on maintenance hemodialysis, particularly in men and in those with severe frailty.
- 10 July 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (10) , 1753-1761
Intradialytic Renal Rehabilitation and Mortality
Key Points: Intradialytic renal rehabilitation was associated with higher 3-year survival in patients on maintenance hemodialysis. This association was directionally consistent after multivariable adjustment and propensity score matching. The association seemed stronger in men with severe frailty; no rehabilitation-related adverse events were reported. Background: Frailty and sarcopenia are increasingly common among patients undergoing maintenance hemodialysis. Globally, some countries, including Japan, have recently introduced insurance reimbursement for intradialytic renal rehabilitation, a supervised intradialytic exercise instruction plus nutritional and lifestyle guidance. However, the survival benefit has not been fully evaluated. Methods: We evaluated 708 adult outpatients on dialysis (age, 69.8±11.2 years; men, 59%; and Clinical Frailty Scale ≥6, 13%) at ten institutions across Japan in January 2021 who were retrospectively assessed over a 3-year period, including 228 patients who received intradialytic renal rehabilitation, defined as supervised intradialytic exercise instruction plus nutritional and lifestyle guidance (≥1 session/wk for≥1 month), and 480 who did not receive this intervention. Cox regression models and propensity score matching were used to compare 3-year mortality after adjustment for the Clinical Frailty Scale, comorbidities, laboratory data, and other baseline characteristics. Results: During the follow-up, deaths were observed in 14.9% of the rehabilitation group and 23.1% of the nonrehabilitation group ( P = 0.01). Three-year survival was higher with rehabilitation (84.6% versus 75.6%, P = 0.007), particularly among men and those with severe frailty. In Cox models, renal rehabilitation was consistently associated with lower mortality (crude hazard ratio [HR], 0.59 [95% confidence interval (CI), 0.40 to 0.87]; adjusted HR 0.66 [0.44 to 1.00]). After propensity score matching, the association remained directionally similar (HR, 0.65 [0.40 to 1.05]). Sex-stratified analyses suggested a stronger association among men (adjusted HR, 0.49 [0.27 to 0.89]) than among women (adjusted HR, 0.98 [0.54 to 1.77]), although the formal test for interaction was not statistically significant ( P for interaction = 0.13). Patients meeting exercise-habit criteria (≥2 sessions/wk, ≥30 minutes for ≥1 year) also showed better survival relative to the nonexercise-habit group (adjusted HR 0.60 [0.37 to 0.96], P = 0.03). No adverse events related to rehabilitation were reported. Conclusions: Intradialytic renal rehabilitation may be associated with better survival in patients on maintenance hemodialysis, particularly in men and in those with severe frailty.
- Open Access
- 22 January 2026
- Published by Springer Nature in Renal Replacement Therapy
- Vol. 12 (1) , 6
Effectiveness of comprehensive medical care support by healthcare professionals, including nurses, in patients undergoing hemodialysis: a systematic review and meta-analysis
Background: Patients undergoing hemodialysis are at increased risk of physical, psychological, and lifestyle-related complications that negatively impact clinical outcomes. Although comprehensive medical care support (CMCS), particularly from nurse-inclusive multidisciplinary teams, may help address these challenges, its effectiveness remains uncertain. This study evaluated the effectiveness of CMCS provided by nurse-inclusive healthcare professionals in improving outcomes among adult patients undergoing hemodialysis. Methods: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) assessing comprehensive care interventions delivered by nurse-inclusive healthcare professionals. Eligible studies included adult patients undergoing hemodialysis and reported outcomes related to physical function, dialysis-related complications, health-related quality of life (HR-QOL), or self-management ability. Literature searches were conducted in MEDLINE (via PubMed) and Ichushi-Web (January 1970–April 2024). The risk of bias was assessed using the Cochrane Risk of Bias Tool (RoB 2) tool, and the certainty of evidence (COE) was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Results: The qualitative synthesis and meta-analysis comprised 25 and 11 RCTs, respectively. A total of 2093 participants were enrolled across the 25 studies. Comprehensive care interventions significantly improved normal gait speed (mean difference [MD] = 10.51 cm/s; 95% confidence interval [CI]: 3.58 to 17.44), systolic blood pressure (MD = −8.07 mmHg; 95% CI −15.57 to −0.58), diastolic blood pressure (MD = −5.79 mmHg; 95% CI −7.89 to −3.69), and the physical component summary of HR-QOL (standardized mean difference = 0.22; 95% CI: 0.003 to 0.44). No significant improvements were observed in the mental component summary of HR-QOL or in self-management outcomes, with high heterogeneity across studies. COE ranged from very low to moderate. Conclusions: CMCS provided by nurse-inclusive healthcare professionals may enhance physical function, blood pressure control, and physical aspects of HR-QOL in patients undergoing hemodialysis. However, further high-quality studies are needed to determine the long-term benefits and to optimize interdisciplinary approaches targeting self-management and psychological outcomes. PROSPERO Registration : CRD42024537551.
- 22 January 2026
- Published by Springer Nature in Renal Replacement Therapy
- Vol. 12 (1) , 6
Open AccessEffectiveness of comprehensive medical care support by healthcare professionals, including nurses, in patients undergoing hemodialysis: a systematic review and meta-analysis
Background: Patients undergoing hemodialysis are at increased risk of physical, psychological, and lifestyle-related complications that negatively impact clinical outcomes. Although comprehensive medical care support (CMCS), particularly from nurse-inclusive multidisciplinary teams, may help address these challenges, its effectiveness remains uncertain. This study evaluated the effectiveness of CMCS provided by nurse-inclusive healthcare professionals in improving outcomes among adult patients undergoing hemodialysis. Methods: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) assessing comprehensive care interventions delivered by nurse-inclusive healthcare professionals. Eligible studies included adult patients undergoing hemodialysis and reported outcomes related to physical function, dialysis-related complications, health-related quality of life (HR-QOL), or self-management ability. Literature searches were conducted in MEDLINE (via PubMed) and Ichushi-Web (January 1970–April 2024). The risk of bias was assessed using the Cochrane Risk of Bias Tool (RoB 2) tool, and the certainty of evidence (COE) was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Results: The qualitative synthesis and meta-analysis comprised 25 and 11 RCTs, respectively. A total of 2093 participants were enrolled across the 25 studies. Comprehensive care interventions significantly improved normal gait speed (mean difference [MD] = 10.51 cm/s; 95% confidence interval [CI]: 3.58 to 17.44), systolic blood pressure (MD = −8.07 mmHg; 95% CI −15.57 to −0.58), diastolic blood pressure (MD = −5.79 mmHg; 95% CI −7.89 to −3.69), and the physical component summary of HR-QOL (standardized mean difference = 0.22; 95% CI: 0.003 to 0.44). No significant improvements were observed in the mental component summary of HR-QOL or in self-management outcomes, with high heterogeneity across studies. COE ranged from very low to moderate. Conclusions: CMCS provided by nurse-inclusive healthcare professionals may enhance physical function, blood pressure control, and physical aspects of HR-QOL in patients undergoing hemodialysis. However, further high-quality studies are needed to determine the long-term benefits and to optimize interdisciplinary approaches targeting self-management and psychological outcomes. PROSPERO Registration : CRD42024537551.
- Open Access
- 21 January 2026
- Published by Springer Nature in Renal Replacement Therapy
- Vol. 12 (1) , 5
Effectiveness of comprehensive medical care support by healthcare professionals, including nurses, in patients with chronic kidney disease: a systematic review and meta-analysis
Background: This study aimed to evaluate the effectiveness of comprehensive medical care support (CMCS) by healthcare professionals, including nurses, for patients with chronic kidney disease (CKD) in the preservation phase. Methods: All relevant studies were identified through comprehensive literature searches conducted in PubMed (MEDLINE) and Ichushi-Web. Randomized controlled trials involving patients aged ≥ 18 years with dialysis-independent CKD were included. The trials had to include nurses in the intervention details and provide CMCS by two or more healthcare professionals. Results: A total of 20 studies were included in the systematic review, of which 14 were eligible for meta-analysis. A significant positive effect of CMCS was observed in terms of physical function, quality of life (QOL), and self-management ability. However, in the pooled analysis, no significant differences regarding renal function and blood pressure were found between the groups. Conclusions: The findings suggest that multidisciplinary team-based CMCS, including nursing involvement, may be associated with improvements in physical function, quality of life, and self-management in patients with CKD; however, substantial heterogeneity across studies warrants cautious interpretation and generalization. PROSPERO registration no. CRD42024529378.
- 21 January 2026
- Published by Springer Nature in Renal Replacement Therapy
- Vol. 12 (1) , 5
Open AccessEffectiveness of comprehensive medical care support by healthcare professionals, including nurses, in patients with chronic kidney disease: a systematic review and meta-analysis
Background: This study aimed to evaluate the effectiveness of comprehensive medical care support (CMCS) by healthcare professionals, including nurses, for patients with chronic kidney disease (CKD) in the preservation phase. Methods: All relevant studies were identified through comprehensive literature searches conducted in PubMed (MEDLINE) and Ichushi-Web. Randomized controlled trials involving patients aged ≥ 18 years with dialysis-independent CKD were included. The trials had to include nurses in the intervention details and provide CMCS by two or more healthcare professionals. Results: A total of 20 studies were included in the systematic review, of which 14 were eligible for meta-analysis. A significant positive effect of CMCS was observed in terms of physical function, quality of life (QOL), and self-management ability. However, in the pooled analysis, no significant differences regarding renal function and blood pressure were found between the groups. Conclusions: The findings suggest that multidisciplinary team-based CMCS, including nursing involvement, may be associated with improvements in physical function, quality of life, and self-management in patients with CKD; however, substantial heterogeneity across studies warrants cautious interpretation and generalization. PROSPERO registration no. CRD42024529378.
- 9 October 2024
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (3) , 471-486
Self-Supervised Learning for Feature Extraction from Glomerular Images and Disease Classification with Minimal Annotations
Key Points: Self-supervised learning extracts meaningful glomerular features without teacher labels. Self-distillation with no labels–pretrained model outperformed conventional supervised learning in disease and clinical parameter classification. Self-distillation with no labels model enabled deep learning on small datasets, reducing annotation efforts. Background: Deep learning has great potential in digital kidney pathology. However, its effectiveness depends heavily on the availability of extensively labeled datasets, which are often limited because of the specialized knowledge and time required for their creation. This limitation hinders the widespread application of deep learning for the analysis of kidney biopsy images. Methods: We applied self-distillation with no labels (DINO), a self-supervised learning method, to a dataset of 10,423 glomerular images obtained from 384 periodic acid–Schiff-stained kidney biopsy slides. Glomerular features extracted from the DINO-pretrained backbone were visualized using principal component analysis. We then performed classification tasks by adding either k-nearest neighbor classifiers or linear head layers to the DINO-pretrained or ImageNet-pretrained backbones. These models were trained on our labeled classification dataset. Performance was evaluated using metrics such as the area under the receiver operating characteristic curve (ROC-AUC). The classification tasks encompassed four disease categories (minimal change disease, mesangial proliferative GN, membranous nephropathy, and diabetic nephropathy) and clinical parameters such as hypertension, proteinuria, and hematuria. Results: Principal component analysis visualization revealed distinct principal components corresponding to different glomerular structures, demonstrating the capability of the DINO-pretrained backbone to capture morphologic features. In disease classification, the DINO-pretrained transferred model (ROC-AUC=0.93) outperformed the ImageNet-pretrained fine-tuned model (ROC-AUC=0.89). When the labeled data were limited, the ImageNet-pretrained fine-tuned model's ROC-AUC dropped to 0.76 (95% confidence interval, 0.72 to 0.80), whereas the DINO-pretrained transferred model maintained superior performance (ROC-AUC, 0.88; 95% confidence interval, 0.86 to 0.90). The DINO-pretrained transferred model also exhibited higher AUCs for the classification of several clinical parameters. External validation using two independent datasets confirmed DINO pretraining's superiority, particularly when labeled data were limited. Conclusions: The application of DINO to unlabeled periodic acid–Schiff-stained glomerular images facilitated the extraction of histologic features that could be effectively used for disease classification.
- 9 October 2024
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (3) , 471-486
Self-Supervised Learning for Feature Extraction from Glomerular Images and Disease Classification with Minimal Annotations
Key Points: Self-supervised learning extracts meaningful glomerular features without teacher labels. Self-distillation with no labels–pretrained model outperformed conventional supervised learning in disease and clinical parameter classification. Self-distillation with no labels model enabled deep learning on small datasets, reducing annotation efforts. Background: Deep learning has great potential in digital kidney pathology. However, its effectiveness depends heavily on the availability of extensively labeled datasets, which are often limited because of the specialized knowledge and time required for their creation. This limitation hinders the widespread application of deep learning for the analysis of kidney biopsy images. Methods: We applied self-distillation with no labels (DINO), a self-supervised learning method, to a dataset of 10,423 glomerular images obtained from 384 periodic acid–Schiff-stained kidney biopsy slides. Glomerular features extracted from the DINO-pretrained backbone were visualized using principal component analysis. We then performed classification tasks by adding either k-nearest neighbor classifiers or linear head layers to the DINO-pretrained or ImageNet-pretrained backbones. These models were trained on our labeled classification dataset. Performance was evaluated using metrics such as the area under the receiver operating characteristic curve (ROC-AUC). The classification tasks encompassed four disease categories (minimal change disease, mesangial proliferative GN, membranous nephropathy, and diabetic nephropathy) and clinical parameters such as hypertension, proteinuria, and hematuria. Results: Principal component analysis visualization revealed distinct principal components corresponding to different glomerular structures, demonstrating the capability of the DINO-pretrained backbone to capture morphologic features. In disease classification, the DINO-pretrained transferred model (ROC-AUC=0.93) outperformed the ImageNet-pretrained fine-tuned model (ROC-AUC=0.89). When the labeled data were limited, the ImageNet-pretrained fine-tuned model's ROC-AUC dropped to 0.76 (95% confidence interval, 0.72 to 0.80), whereas the DINO-pretrained transferred model maintained superior performance (ROC-AUC, 0.88; 95% confidence interval, 0.86 to 0.90). The DINO-pretrained transferred model also exhibited higher AUCs for the classification of several clinical parameters. External validation using two independent datasets confirmed DINO pretraining's superiority, particularly when labeled data were limited. Conclusions: The application of DINO to unlabeled periodic acid–Schiff-stained glomerular images facilitated the extraction of histologic features that could be effectively used for disease classification.
- Open Access
- 28 September 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blind randomized controlled trial
Reportedly, nausea or vomiting after heavy exercise was associated with post-exercise increased blood calcium (Ca) levels, which was correlated with enhanced bone resorption. We conducted a randomized, double-blind, placebo-controlled trial, enrolling 104 healthy trained male members of the Japan Ground Self-Defense Forces. Risedronate (17.5 mg) or placebo was prescribed 3 and 10 days before heavy exercise lasting approximately 5 h. The primary outcome was the severity of nausea or vomiting assessed by a visual analog scale during or post-exercise. The secondary outcomes included clinical symptoms associated with heat illness, post-exercise serum total Ca (tCa), whole blood ionized Ca (iCa), and serum tartrate-resistant acid phosphatase 5b (TRACP-5b) levels. The mean age was 26 years. The exercise resulted in a 4.5% weight loss. The two groups were comparable in terms of the symptoms, including primary outcome. However, post-exercise tCa and TRACP-5b were significantly lower with risedronate. A similar result was observed for iCa. The post-exercise urinary Ca/Magnesium ratio and the incidence of hypercalcemia (defined as tCa or iCa levels ≥ each median value of all subjects) were significantly lower with risedronate (78.0% vs. 58.5%). A stronger treatment effect of risedronate on blood Ca levels was observed in participants who lost substantial body weight. Post-exercise hypercalcemia is attributed to enhanced bone resorption but not the cause of nausea.
- 28 September 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Open AccessRisedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blind randomized controlled trial
Reportedly, nausea or vomiting after heavy exercise was associated with post-exercise increased blood calcium (Ca) levels, which was correlated with enhanced bone resorption. We conducted a randomized, double-blind, placebo-controlled trial, enrolling 104 healthy trained male members of the Japan Ground Self-Defense Forces. Risedronate (17.5 mg) or placebo was prescribed 3 and 10 days before heavy exercise lasting approximately 5 h. The primary outcome was the severity of nausea or vomiting assessed by a visual analog scale during or post-exercise. The secondary outcomes included clinical symptoms associated with heat illness, post-exercise serum total Ca (tCa), whole blood ionized Ca (iCa), and serum tartrate-resistant acid phosphatase 5b (TRACP-5b) levels. The mean age was 26 years. The exercise resulted in a 4.5% weight loss. The two groups were comparable in terms of the symptoms, including primary outcome. However, post-exercise tCa and TRACP-5b were significantly lower with risedronate. A similar result was observed for iCa. The post-exercise urinary Ca/Magnesium ratio and the incidence of hypercalcemia (defined as tCa or iCa levels ≥ each median value of all subjects) were significantly lower with risedronate (78.0% vs. 58.5%). A stronger treatment effect of risedronate on blood Ca levels was observed in participants who lost substantial body weight. Post-exercise hypercalcemia is attributed to enhanced bone resorption but not the cause of nausea.
- Open Access
- 7 September 2024
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 55 (6) , 1-10
Association between Timing of Vascular Access Creation and Mortality in Patients Initiating Hemodialysis: A Nationwide Cohort Study in Japan
Introduction: The optimal time for vascular access (VA) creation remains controversial. Methods: We conducted a cohort study using data from the Japanese Society for Dialysis Therapy Renal Data Registry. Adult patients who started receiving hemodialysis in 2007 and had a permanent VA created were included. The exposure of interest was the timing of VA creation, categorized into three groups: early VA creation (defined as creation at least 4 months before hemodialysis initiation), just prior VA creation (creation between 1 and 3 months before hemodialysis initiation), and late VA creation (creation within 1 month of or after hemodialysis initiation). Cox regression analyses were used to compare 1-year all-cause mortality, with late VA creation as the reference group. Owing to the violations of the proportional hazards assumptions, the follow-up period was divided into “early” (1–4 months follow-up) and “late” (5–12 months follow-up) periods. Results: Overall, 1,280 (15.4%) of 8,322 patients died. Both early creation and just prior creation were associated with lower all-cause mortality in the early period compared with late creation. In the late period, the hazard ratios (HRs) for all-cause mortality decreased with earlier VA creation (adjusted HRs [95% confidence intervals]: 0.49 [0.35–0.67] for the early creation group and 0.63 [0.51–0.79] for the just prior creation group). Conclusion: Our study suggests that VA creation at least 1 month before hemodialysis initiation is associated with lower all-cause mortality in the early period, with earlier VA creation resulting in further mortality reduction in the late period.
- 7 September 2024
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 55 (6) , 1-10
Open AccessAssociation between Timing of Vascular Access Creation and Mortality in Patients Initiating Hemodialysis: A Nationwide Cohort Study in Japan
Introduction: The optimal time for vascular access (VA) creation remains controversial. Methods: We conducted a cohort study using data from the Japanese Society for Dialysis Therapy Renal Data Registry. Adult patients who started receiving hemodialysis in 2007 and had a permanent VA created were included. The exposure of interest was the timing of VA creation, categorized into three groups: early VA creation (defined as creation at least 4 months before hemodialysis initiation), just prior VA creation (creation between 1 and 3 months before hemodialysis initiation), and late VA creation (creation within 1 month of or after hemodialysis initiation). Cox regression analyses were used to compare 1-year all-cause mortality, with late VA creation as the reference group. Owing to the violations of the proportional hazards assumptions, the follow-up period was divided into “early” (1–4 months follow-up) and “late” (5–12 months follow-up) periods. Results: Overall, 1,280 (15.4%) of 8,322 patients died. Both early creation and just prior creation were associated with lower all-cause mortality in the early period compared with late creation. In the late period, the hazard ratios (HRs) for all-cause mortality decreased with earlier VA creation (adjusted HRs [95% confidence intervals]: 0.49 [0.35–0.67] for the early creation group and 0.63 [0.51–0.79] for the just prior creation group). Conclusion: Our study suggests that VA creation at least 1 month before hemodialysis initiation is associated with lower all-cause mortality in the early period, with earlier VA creation resulting in further mortality reduction in the late period.
- Open Access
- 14 March 2023
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 54 (3-4) , 83-94
Association of Four Types of Vascular Access Including Arterial Superficialization with Mortality in Maintenance Hemodialysis Patients: A Nationwide Cohort Study in Japan
Introduction: Vascular access usage varies widely across countries. Previous studies have evaluated the association of clinical outcomes with the three types of vascular access, namely, arteriovenous fistula (AVF), arteriovenous graft (AVG), and tunneled and cuffed central venous catheter (TC-CVC). However, little is known regarding the association between arterial superficialization (AS) and the mortality of patients. Methods: A nationwide cohort study was conducted using data from the Japanese Society for Dialysis Therapy Renal Data Registry (2006–2007). We included patients aged ≥20 years undergoing hemodialysis with a dialysis vintage ≥6 months. The exposures of interest were the four types of vascular access: AVF, AVG, AS, and TC-CVC. Cox proportional hazard models were used to evaluate the associations of vascular access types with 1-year all-cause and cause-specific mortality. Results: A total of 183,490 maintenance hemodialysis patients were included: 90.7% with AVF, 6.9% with AVG, 2.0% with AS, and 0.4% with TC-CVC. During the 1-year follow-up period, 13,798 patients died. Compared to patients with AVF, those with AVG, AS, and TC-CVC had a significantly higher risk of all-cause mortality after adjustment for confounding factors: adjusted hazard ratios (95% confidence intervals) – 1.30 (1.20–1.41), 1.56 (1.39–1.76), and 2.15 (1.77–2.61), respectively. Similar results were obtained for infection-related and cardiovascular mortality. Conclusion: This nationwide cohort study conducted in Japan suggested that AVF usage may have the lowest risk of all-cause mortality. The study also suggested that the usage of AS may be associated with better survival rates compared to those of TC-CVC in patients who are not suitable for AVF or AVG.
- 14 March 2023
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 54 (3-4) , 83-94
Open AccessAssociation of Four Types of Vascular Access Including Arterial Superficialization with Mortality in Maintenance Hemodialysis Patients: A Nationwide Cohort Study in Japan
Introduction: Vascular access usage varies widely across countries. Previous studies have evaluated the association of clinical outcomes with the three types of vascular access, namely, arteriovenous fistula (AVF), arteriovenous graft (AVG), and tunneled and cuffed central venous catheter (TC-CVC). However, little is known regarding the association between arterial superficialization (AS) and the mortality of patients. Methods: A nationwide cohort study was conducted using data from the Japanese Society for Dialysis Therapy Renal Data Registry (2006–2007). We included patients aged ≥20 years undergoing hemodialysis with a dialysis vintage ≥6 months. The exposures of interest were the four types of vascular access: AVF, AVG, AS, and TC-CVC. Cox proportional hazard models were used to evaluate the associations of vascular access types with 1-year all-cause and cause-specific mortality. Results: A total of 183,490 maintenance hemodialysis patients were included: 90.7% with AVF, 6.9% with AVG, 2.0% with AS, and 0.4% with TC-CVC. During the 1-year follow-up period, 13,798 patients died. Compared to patients with AVF, those with AVG, AS, and TC-CVC had a significantly higher risk of all-cause mortality after adjustment for confounding factors: adjusted hazard ratios (95% confidence intervals) – 1.30 (1.20–1.41), 1.56 (1.39–1.76), and 2.15 (1.77–2.61), respectively. Similar results were obtained for infection-related and cardiovascular mortality. Conclusion: This nationwide cohort study conducted in Japan suggested that AVF usage may have the lowest risk of all-cause mortality. The study also suggested that the usage of AS may be associated with better survival rates compared to those of TC-CVC in patients who are not suitable for AVF or AVG.
- Open Access
- 28 February 2022
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 53 (2-3) , 226-239
A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan
Introduction: Recent studies have suggested a higher incidence of cardiovascular disease (CVD) among patients with chronic kidney disease (CKD) in the USA than in Japan. Hyperphosphatemia, a possible risk for CVD, may explain this difference; however, international differences in phosphate parameters in CKD have not been well elaborated. Methods: By using the baseline data from the USA and the Japanese nation-wide, multicenter, CKD cohort studies; the Chronic Renal Insufficiency Cohort Study (CRIC, N = 3,870) and the Chronic Kidney Disease-Japan Cohort Study (CKD-JAC, N = 2,632), we harmonized the measures and compared clinical parameters regarding phosphate metabolism or serum phosphate, fibroblast growth factor-23 (FGF23), and parathyroid hormone (PTH), in the cross-sectional model. Results: Multivariable linear regression analyses revealed that serum phosphate levels were significantly higher in CRIC across all levels of estimated glomerular filtration rate (eGFR) with the greatest difference being observed at lower levels of eGFR. Serum FGF23 and 25-hydroxy vitamin D (25OHD) levels were higher in CRIC, while PTH levels were higher in CKD-JAC at all levels of eGFR. Adjustments for demographics, 25OHD, medications, dietary intake or urinary excretion of phosphate, PTH, and FGF23 did not eliminate the difference in serum phosphate levels between the cohorts (0.43, 0.46, 0.54, 0.64, and 0.78 mg/dL higher in CRIC within eGFR strata of >50, 41–50, 31–40, 21–30, and ≤20 mL/min/1.73 m2, respectively). These findings were consistent when only Asian CRIC participants (N = 105) were included in the analysis. Conclusion: Serum phosphate levels in CRIC were significantly higher than those of CKD-JAC across all stages of CKD, which may shed light on the international variations in phosphate parameters and thus in cardiovascular risk among CKD patients. The key mechanisms for the substantial differences in phosphate parameters need to be elucidated.
- 28 February 2022
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 53 (2-3) , 226-239
Open AccessA Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan
Introduction: Recent studies have suggested a higher incidence of cardiovascular disease (CVD) among patients with chronic kidney disease (CKD) in the USA than in Japan. Hyperphosphatemia, a possible risk for CVD, may explain this difference; however, international differences in phosphate parameters in CKD have not been well elaborated. Methods: By using the baseline data from the USA and the Japanese nation-wide, multicenter, CKD cohort studies; the Chronic Renal Insufficiency Cohort Study (CRIC, N = 3,870) and the Chronic Kidney Disease-Japan Cohort Study (CKD-JAC, N = 2,632), we harmonized the measures and compared clinical parameters regarding phosphate metabolism or serum phosphate, fibroblast growth factor-23 (FGF23), and parathyroid hormone (PTH), in the cross-sectional model. Results: Multivariable linear regression analyses revealed that serum phosphate levels were significantly higher in CRIC across all levels of estimated glomerular filtration rate (eGFR) with the greatest difference being observed at lower levels of eGFR. Serum FGF23 and 25-hydroxy vitamin D (25OHD) levels were higher in CRIC, while PTH levels were higher in CKD-JAC at all levels of eGFR. Adjustments for demographics, 25OHD, medications, dietary intake or urinary excretion of phosphate, PTH, and FGF23 did not eliminate the difference in serum phosphate levels between the cohorts (0.43, 0.46, 0.54, 0.64, and 0.78 mg/dL higher in CRIC within eGFR strata of >50, 41–50, 31–40, 21–30, and ≤20 mL/min/1.73 m2, respectively). These findings were consistent when only Asian CRIC participants (N = 105) were included in the analysis. Conclusion: Serum phosphate levels in CRIC were significantly higher than those of CKD-JAC across all stages of CKD, which may shed light on the international variations in phosphate parameters and thus in cardiovascular risk among CKD patients. The key mechanisms for the substantial differences in phosphate parameters need to be elucidated.
- 17 June 2021
- Published by Springer Nature in Osteoporosis International
- Vol. 32 (12) , 2533-2541
Exercise-induced hypercalcemia and vasopressin-mediated bone resorption
Summary Our human observational study showed that elevated arginine vasopressin levels by heavy exercise, not catecholamines, were associated with elevated serum tartrate-resistant acid phosphatase 5b (TRACP-5b). The increase in serum calcium was positively associated with percent changes of TRACP-5b, implying the involvement of bone resorption in the pathogenesis of exercise-induced hypercalcemia. Introduction It remains unclear whether enhanced bone resorption explains exercise-induced hypercalcemia. An experimental study demonstrated that arginine vasopressin (AVP) stimulated osteoclast activity. Methods We conducted a prospective observational study, enrolling 65 trained healthy male officers of the Japan Self-Defense Forces (34 and 31 in waves 1 and 2, respectively). Before and after a 5-h heavy exercise, we collected laboratory data including bone markers, symptoms, and ionized calcium (iCa; wave 2 only). As blood calcium levels change after exercise, we estimated calcium (corrected calcium) levels immediately after the exercise using the correlation between blood calcium and time from the end of exercise in another cohort. Results Body weight decreased by 6.9% after the exercise. Corrected post-exercise serum total calcium (tCa) and iCa levels were significantly higher than pre-exercise levels, and 18% of participants showed hypercalcemia defined as corrected tCa >10.4 mg/dL or iCa >1.30 mmol/L. Serum tartrate-resistant acid phosphatase 5b (TRACP-5b), plasma three fractions of catecholamines, and AVP elevated significantly (median 14.3 pg/mL), while procollagen type 1 N-terminal propeptide and whole parathyroid hormone showed significant decreases. Corrected tCa increase showed a non-linear positive association with percent changes of TRACP-5b (%ΔTRACP-5b) even after adjustment for confounders. In addition, %ΔTRACP-5b was not associated with catecholamines, but with post-exercise AVP levels after adjustment for pre-exercise TRACP-5b. Symptoms of nausea or vomiting (observed in 20%) were positively associated with corrected post-exercise iCa after adjustment for post-exercise blood pH. Conclusion AVP elevation may explain bone resorption and the following hypercalcemia in the setting of heavy exercise.
- 17 June 2021
- Published by Springer Nature in Osteoporosis International
- Vol. 32 (12) , 2533-2541
Exercise-induced hypercalcemia and vasopressin-mediated bone resorption
Summary Our human observational study showed that elevated arginine vasopressin levels by heavy exercise, not catecholamines, were associated with elevated serum tartrate-resistant acid phosphatase 5b (TRACP-5b). The increase in serum calcium was positively associated with percent changes of TRACP-5b, implying the involvement of bone resorption in the pathogenesis of exercise-induced hypercalcemia. Introduction It remains unclear whether enhanced bone resorption explains exercise-induced hypercalcemia. An experimental study demonstrated that arginine vasopressin (AVP) stimulated osteoclast activity. Methods We conducted a prospective observational study, enrolling 65 trained healthy male officers of the Japan Self-Defense Forces (34 and 31 in waves 1 and 2, respectively). Before and after a 5-h heavy exercise, we collected laboratory data including bone markers, symptoms, and ionized calcium (iCa; wave 2 only). As blood calcium levels change after exercise, we estimated calcium (corrected calcium) levels immediately after the exercise using the correlation between blood calcium and time from the end of exercise in another cohort. Results Body weight decreased by 6.9% after the exercise. Corrected post-exercise serum total calcium (tCa) and iCa levels were significantly higher than pre-exercise levels, and 18% of participants showed hypercalcemia defined as corrected tCa >10.4 mg/dL or iCa >1.30 mmol/L. Serum tartrate-resistant acid phosphatase 5b (TRACP-5b), plasma three fractions of catecholamines, and AVP elevated significantly (median 14.3 pg/mL), while procollagen type 1 N-terminal propeptide and whole parathyroid hormone showed significant decreases. Corrected tCa increase showed a non-linear positive association with percent changes of TRACP-5b (%ΔTRACP-5b) even after adjustment for confounders. In addition, %ΔTRACP-5b was not associated with catecholamines, but with post-exercise AVP levels after adjustment for pre-exercise TRACP-5b. Symptoms of nausea or vomiting (observed in 20%) were positively associated with corrected post-exercise iCa after adjustment for post-exercise blood pH. Conclusion AVP elevation may explain bone resorption and the following hypercalcemia in the setting of heavy exercise.
- Open Access
- 1 May 2017
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 32 (suppl_3) , iii196
SP267RED CELL DISTRIBUTION WIDTH AND RENAL OUTCOME IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS
INTRODUCTION AND AIMS: Red cell distribution width (RDW) has been reported as a predictive marker of mortality among patients with various diseases. A recent study showed higher RDW was associated with higher mortality also in patients with chronic kidney disease (CKD). However, it remains still unknown whether RDW is associated with renal outcome in this population.
- 1 May 2017
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 32 (suppl_3) , iii196
Open AccessSP267RED CELL DISTRIBUTION WIDTH AND RENAL OUTCOME IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS
INTRODUCTION AND AIMS: Red cell distribution width (RDW) has been reported as a predictive marker of mortality among patients with various diseases. A recent study showed higher RDW was associated with higher mortality also in patients with chronic kidney disease (CKD). However, it remains still unknown whether RDW is associated with renal outcome in this population.